Chrysomycin A

Chrysomycin A

$315.00 - 0.50 mg

$1,105.00 - 2.50 mg

All prices in Australian dollars

Chrysomycin V, Virenomycin V, Albacarcin V,
Molecular Formula
Molecular Weight
>95% by HPLC
Long Term Storage
Soluble in DMF or DMSO. Moderately soluble in methanol or ethanol. Poor water solubility.

Download Data Sheets

Application Notes

Chrysomycin A is the major analogue in a complex of C-glycoside antitumor actives isolated from Streptomyces. Chrysomycin A, with a vinyl group in the 8-position, is the most potent analogue of the complex, and is thought to act as an inhibitor of the catalytic activity of human topoisomerase II. Chrysomycin A has a potent antibacterial, antifungal, antiviral and antitumor profile. More recent research on related metabolites, the gilvocarcins, suggests that chrysomycins may act as photoactivated cross-linkers of DNA to histones.


  • Biochemical characterisation of elsamicin and other coumarin-related antitumor agents as potent inhibitors of human topoisomerase II. Lorico A. et al., Eur. J. Cancer. 1993, 29A, 1985.
  • Chrysomycin derivative compounds and use as antitumor agents. US Patent 6,030,951, 2000.
  • Histone H3 and heat shock protein GRP78 are selectively cross-linked to DNA by photoactivated gilvocarcin V in human fibroblasts. Matsumoto A. et al., Cancer Res. 2000, 60, 3921.

Other Products